- Sugar.fit secured $11 million in funding from investors like MassMutual Ventures, Tanglin Venture Partners, Endiya Partners, and Cure.Fit.
- The startup plans to enhance its technology, strengthen its brand presence, and accelerate research and development in diabetes management.
- Sugar.fit had previously raised $10 million in a seed funding round with support from investors like MassMutual Ventures, B Capital, Curefit, Endiya Partners, and Tanglin Venture Partners.
Last year in October, Sugar.fit managed to secure a whopping $11 million in funding from notable investors including MassMutual Ventures, Tanglin Venture Partners, Endiya Partners, and Cure.Fit.
With this significant financial boost, the startup aims to enhance its technology and product offerings, strengthen its brand presence, and accelerate research and development in the field of diabetes management.
Founded by Madan Somasundaram and Shivtosh Kumar in 2021, Sugar.fit is dedicated to providing healthtech solutions for diabetes management and reversal through data-driven methods.
The company has already made its mark in Bangalore, operating seven Diabetes Clinics across the city. In the same year, Sugar.fit successfully raised $10 million in a seed funding round, receiving support from prominent investors like MassMutual Ventures, B Capital, Curefit, Endiya Partners, and Tanglin Venture Partners.
In a similar vein, Zeno Health recently made headlines by securing $25 million in its Series C funding round, with STIC Investments and Lightbox leading the investment.
Furthermore, CureBay, another health-tech startup, announced its successful Series A1 funding round, raising INR 62 crore (approximately $7.4 million) with Elevar Equity as the primary investor.
Edited by Shruti Thapa
